Latest Updates

News, Stories & Healthcare Insights

✨An evening of connection in Milan at CPHI 2026

After an exciting first day at CPHI Milan, our team had the opportunity to come together with partners and colleagues for an evening of good food, great conversations and...

🌍 CPHI Milan 2026 is officially underway! 🎉

Our booth is already buzzing with energy, and our team is thrilled to be here in Milan – reconnecting with familiar faces, meeting new partners and exchanging ideas. 🤝...

🌍Six languages, one shared message: we look forward to meeting you at CPHI Milan next week!

One week to go until CPHI 2026.⏳ From 6 – 8 October, the global pharmaceutical community will come together at Fiera Milano – and our international team is ready...

🏭Successful Completion of our New Production Block in Hyderabad, India

Expanding our manufacturing capabilities is an important step in our mission to make high-quality medicines more affordable and accessible to patients around the world. 🌍💊 We are proud to...

Better Therapies for Patients Worldwide

At Tiefenbacher Group, our focus goes beyond developing medicines. We create value-added and innovative therapies by understanding the needs and challenges of everyday healthcare. By listening to patients and...

See you at CPHI 2026!

We are excited to be joining the global pharmaceutical community at CPHI 2026, taking place from 6 to 8 October at Fiera Milano, Italy. 🌍💊 hashtag#CPHIMilan creates a valuable...

Better Affordability of Medicines

Better affordability of medicines starts with a smarter, more efficient supply chain. As our in-house manufactured portfolio continues to grow, we are strengthening our ability to simplify supply, leverage...

💊Active pharmaceutical ingredients (APIs) rarely make headlines. Yet, without them, there are no medicines

For more than 60 years, Tiefenbacher API + Ingredients has helped pharmaceutical companies across Europe secure reliable access to high-quality APIs.🌍 Today, our portfolio includes more than 2.000 APIs...

Did you know that one of Tiefenbacher’s first innovations wasn’t a medicine – but a completely new way of working?

When Alfred E. Tiefenbacher founded Tiefenbacher Group in 1963, active pharmaceutical ingredients were often traded anonymously, with price taking priority over transparency. Alfred believed there was a better way....

🌍 Connecting Sites, Strengthening Supply Chains: Meet Michael 👋

Meet Michael Stavrou, MCIPS, the first Supply Chain Operations Manager within our Supply Chain In-House Team who is based at Tiefenbacher’s manufacturing site in Cyprus. Michael is currently spending...

We are proud to announce the launch of Edoxaban in Romania, Estonia, and Latvia 💊

Edoxaban is an anticoagulant (“blood thinner”) used in adults with non-valvular atrial fibrillation to help prevent stroke and systemic embolism. It is also used to treat deep vein thrombosis...

Some buildings tell the story of a city. Ours is one of them. 🏢 ✨

Completed in 1993, the building that houses Tiefenbacher Group was originally designed as Hamburg’s England Terminal, a ferry terminal connecting the city with Harwich in the United Kingdom. With...